NO980299D0 - Cytokine production inhibitors, their preparations and their use in medicine, as well as methods for their identification - Google Patents

Cytokine production inhibitors, their preparations and their use in medicine, as well as methods for their identification

Info

Publication number
NO980299D0
NO980299D0 NO980299A NO980299A NO980299D0 NO 980299 D0 NO980299 D0 NO 980299D0 NO 980299 A NO980299 A NO 980299A NO 980299 A NO980299 A NO 980299A NO 980299 D0 NO980299 D0 NO 980299D0
Authority
NO
Norway
Prior art keywords
preparations
medicine
identification
methods
well
Prior art date
Application number
NO980299A
Other languages
Norwegian (no)
Other versions
NO980299L (en
Inventor
Paul Thornalley
Original Assignee
Wivenhoe Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wivenhoe Technology Ltd filed Critical Wivenhoe Technology Ltd
Publication of NO980299D0 publication Critical patent/NO980299D0/en
Publication of NO980299L publication Critical patent/NO980299L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO980299A 1996-05-25 1998-01-23 Cytokine production inhibitors, their preparations and their use in medicine, as well as methods for their identification NO980299L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9611046.5A GB9611046D0 (en) 1996-05-25 1996-05-25 Pharmacological compounds
PCT/GB1997/001415 WO1997045417A1 (en) 1996-05-25 1997-05-23 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification

Publications (2)

Publication Number Publication Date
NO980299D0 true NO980299D0 (en) 1998-01-23
NO980299L NO980299L (en) 1998-03-24

Family

ID=10794362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980299A NO980299L (en) 1996-05-25 1998-01-23 Cytokine production inhibitors, their preparations and their use in medicine, as well as methods for their identification

Country Status (10)

Country Link
EP (1) EP0859762A1 (en)
JP (1) JPH11510521A (en)
AU (1) AU2910397A (en)
BR (1) BR9702238A (en)
CA (1) CA2227811A1 (en)
GB (1) GB9611046D0 (en)
HU (1) HUP9902796A3 (en)
IL (1) IL123033A0 (en)
NO (1) NO980299L (en)
WO (1) WO1997045417A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592348B2 (en) 2003-12-15 2009-09-22 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7700603B2 (en) 2003-12-15 2010-04-20 Schering Corporation Heterocyclic aspartyl protease inhibitors
CN1968945A (en) 2004-06-16 2007-05-23 惠氏公司 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase
JP2008503460A (en) 2004-06-16 2008-02-07 ワイス Diphenylimidazopyrimidine and imidazolamine as inhibitors of β-secretase
RU2007126570A (en) 2005-01-14 2009-02-20 Вайет (Us) AMINOIMIDAZOLES USED FOR INHIBITING BETA SECRETASES
WO2006083760A1 (en) 2005-02-01 2006-08-10 Wyeth AMINO-PYRIDINES AS INHIBITORS OF β-SECRETASE
WO2006088711A1 (en) 2005-02-14 2006-08-24 Wyeth AZOLYLACYLGUANIDINES AS β-SECRETASE INHIBITORS
TW200738683A (en) 2005-06-30 2007-10-16 Wyeth Corp Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
WO2007038271A1 (en) 2005-09-26 2007-04-05 Wyeth Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace)
WO2007100536A1 (en) 2006-02-24 2007-09-07 Wyeth DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
US7700606B2 (en) 2006-08-17 2010-04-20 Wyeth Llc Imidazole amines as inhibitors of β-secretase
AU2007332754A1 (en) 2006-12-12 2008-06-19 Schering Corporation Aspartyl protease inhibitors
AR065814A1 (en) 2007-03-23 2009-07-01 Wyeth Corp DERIVATIVES OF 5-PHENYLIMIDAZOLONE, INHIBITORS OF BETA-SECRETASA, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USES TO PREVENT AND / OR TREAT ASSOCIATED DISORDERS AT LEVELS BETA-AMYLOOES ELEVATED.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005205A (en) * 1974-04-24 1977-01-25 Smith Kline & French Laboratories Limited Compositions and methods for inhibiting H2 histamine receptors
EP0102026A3 (en) * 1982-08-20 1984-05-16 Hoechst Uk Limited Thiazole derivatives
US4572908A (en) * 1982-12-21 1986-02-25 Pfizer Inc. Dihydropyridines
GB8311443D0 (en) * 1983-04-27 1983-06-02 Smith Kline French Lab Chemical compounds
AU5428686A (en) * 1985-03-12 1986-09-18 Smith Kline & French Laboratories Limited Imidazolinone and thiazolinone derivatives
FI902321A0 (en) * 1989-05-19 1990-05-09 Eisai Co Ltd BUTENSYRADERIVAT.
GB9506188D0 (en) * 1995-03-27 1995-05-17 Fujisawa Pharmaceutical Co Amidine derivatives

Also Published As

Publication number Publication date
MX9800670A (en) 1998-09-30
AU2910397A (en) 1998-01-05
EP0859762A1 (en) 1998-08-26
GB9611046D0 (en) 1996-07-31
HUP9902796A3 (en) 2000-07-28
IL123033A0 (en) 1998-09-24
NO980299L (en) 1998-03-24
JPH11510521A (en) 1999-09-14
HUP9902796A2 (en) 2000-04-28
WO1997045417A1 (en) 1997-12-04
BR9702238A (en) 1999-07-27
CA2227811A1 (en) 1997-12-04

Similar Documents

Publication Publication Date Title
IT1271508B (en) BLOCKED ENDOMIDOLLAR NAIL SUITABLE FOR HUMERUS PARTICULAR
DK0836615T3 (en) New thrombin inhibitors, their preparation and use
IT1275300B (en) BLOCKED ENDOMIDOLLAR NAIL SUITABLE FOR FEMORE FRACTURES IN PARTICULAR
DK617288D0 (en) CLEANING INHIBITORS, THEIR PREPARATION AND USE
DK543189D0 (en) LYSYLOXIDASE INHIBITORS AND THEIR USE
NO20015278D0 (en) 6-Alkenyl, 6-alkynyl and 6-epoxy-epothilone derivatives, process for their preparation and their use in pharmaceutical preparations
DK273689A (en) 4-AMINO-3-CARBOXYQUINOLINES AND -NAPHTHYRIDINES, PROCEDURES FOR THEIR PREPARATION AND USE OF THEM IN PHARMACEUTICALS
DK641589A (en) N-ARYL-AZETIDINONES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS ELASTASE INHIBITORS
NO980299D0 (en) Cytokine production inhibitors, their preparations and their use in medicine, as well as methods for their identification
NO975020D0 (en) Azacycloalkane derivatives, their preparation and their use in therapy
NO981322D0 (en) Pharmaceutical preparations for use in nucleic acid transfection, and their use
DK530689D0 (en) ADENYLYCYCLASE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND THEIR USE
NO954763D0 (en) Piperidine derivatives, their preparation and use
DK633789D0 (en) BENZOTHIAZOL DERIVATIVES, THEIR PREPARATION AND USE IN PHARMACEUTICALS
NO940130D0 (en) Benzimidazole derivatives, methods for their preparation and the therapeutic use thereof
NO884671D0 (en) NEW FLOURMETOXYPHENYLNEDHYDROPYRIDINES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICALS.
EE9800333A (en) Novel furanarylmethylidene derivatives, methods for their preparation and use in therapy
DK360189D0 (en) S-ADENOSYL-METHIONIN-DECARBOXYLASE INHIBITORS, THEIR PREPARATION AND USE
DK82186A (en) CEPHALOSPORINES, PROCEDURES FOR PRODUCING THEREOF AND THEIR USE IN PHARMACEUTICALS
NO930390L (en) NEW HETARYLOXY-BETA CARBOLINES, THEIR PREPARATION AND USE IN PHARMACEUTICALS
NO893756D0 (en) BASIC 4-ARYL-DHP AMIDES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICALS.
NO902248L (en) PURE-INHIBITING PEPTIDES, THEIR PREPARATION AND USE IN PHARMACEUTICALS.
DK358389A (en) 4-HALOGEN-5-NITROTHIAZOL DERIVATIVES, PROCEDURES AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE
NO20025028D0 (en) 9-Oxa Epotilone Derivatives, Processes for their Preparation and Their Use in Pharmaceutical Preparations
NO992310D0 (en) Inhibitors and their use in oils